We recently published 10 Double-Digit Winners You Wish You Bought Yesterday. Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is one of the last week’s top performers. Arrowhead Pharmaceuticals soared by ...

Bernstein analyst William Pickering maintained a Hold rating on Arrowhead Pharmaceuticals on August 15 and set a price target of $17.00. The company’s shares closed last Friday at $20.51. Take ...

A refinancing deal will delay the maturity of $700 million in debt until 2030, allowing the company to “fully fund” its ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Alkermes (ALKS – Research Report), Staar Surgical (STAA – Research Report) and Arvinas Holdin ...

In this week’s edition of InnovationRx, we look at Phil Knight’s big cancer gift, Medallion’s credentialing clearinghouse, a ...

Learn more about whether ADMA Biologics, Inc. or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ ...

Three speakers outlined how AI is likely to have a major impact on the future of preventive cardiology.At the American ...

Sarepta Therapeutics, Inc. (SRPT) announced on Thursday that it has entered into agreements with investors to restructure ...

Last week, PureTech Health spun out a new company, Celea Therapeutics, which will develop its pulmonary fibrosis candidate ...

Arrowhead Clinic is excited to introduce a new range of services that focus on car accident injuries, providing patients in ...

Arrowhead Clinic in Garden City is excited to announce a new resource available on their WordPress site detailing advanced ...

TAMPA, FLORIDA / ACCESS Newswire / August 20, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (“Wellgistics Health” or the ...